Metotrexato en pacientes con artritis reumatoide en España: subanálisis del proyecto AR Excellence-Reference-Cited by-同舟云学术

Metotrexato en pacientes con artritis reumatoide en España: subanálisis del proyecto AR Excellence

Published:2019-11 Issue:6 Volume:15 Page:338-342
ISSN:1699-258X
Container-title:Reumatología Clínica
language:es
Short-container-title:Reumatología Clínica

Author:

Tornero-Molina Jesús,Andreu José Luis,Martín-Martínez María-Auxiliadora,Corominas Héctor,Pérez Venegas José Javier,Román-Ivorra José Andrés,Sánchez-Alonso Fernando

Publisher

Elsevier BV

Subject

Rheumatology

Reference30 articles.

1. Low-dose methotrexate (LD-MTX) in rheumatology practice-a most widely misunderstood drug;Malaviya;Curr Rheumatol Rev,2016

2. 2014 update of the consensus statement of the Spanish Society of Rheumatology on the use of biological therapies in rheumatoid arthritis;Sanmarti;Reumatol Clin,2015

3. Recommendations of the French Society for Rheumatology fot managing rheumatoid arthritis;Gaujoux-Viala;Joint Bone Spine,2014

4. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update;Smolen;Ann Rheum Dis,2014

5. Determining best practices in early rheumatoid arhritis by comparing differences in treatment at sites in the Canadian Early Arthitis Cohort;Harris;J Rheumatol,2013

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Initial Treatment with Biological Therapy in Rheumatoid Arthritis;Journal of Clinical Medicine;2023-12-21

2. Barriers and Enablers in the Use of Parenteral Methotrexate in Rheumatoid Arthritis Patients: A Scoping Review;Arthritis Care & Research;2023-06-12

3. Potential Benefits of the Self-Administration of Subcutaneous Methotrexate with Autoinjector Devices for Patients: A Review;Drug, Healthcare and Patient Safety;2021-03

4. Causes of synthetic disease-modifying drug discontinuation in rheumatoid arthritis: Data from a large real-life cohort;PLOS ONE;2019-03-01